Abstract
The present invention relates to compositions and methods for the application of tolerance-promoting adjuvants embedded in alum-, microcrystalline tyrosine-, or hydrogel-based formulations for allergen- or autoantigen-specific immunotherapy.
Original language | English |
---|---|
IPC | EP3251662,US2018/0085452 |
Publication status | Published - 6 Dec 2017 |